Home

Studies

Retatrutide triple agonist obesity trial

Retatrutide triple agonist obesity trial

New England Journal of Medicine

2023

Study summary

Retatrutide investigated as GLP-1/GIP/glucagon receptor agonist.

Open full study

Peptides studied

Retatrutide

Goals studied

Peptides for Fat Loss

Peptides for Metabolism

Stack studied

Advanced Metabolic Stack

Key findings

Marked reductions in body weight and metabolic improvements observed.

Study details

Study type

phase 2 clinical trial

Journal

New England Journal of Medicine

DOI / PubMed

10.1056/NEJMoa2301972

Year

2023

Explore peptide profiles

Discover compounds, understand their mechanisms, and explore the research behind each peptide.

View all peptides

Peptides

Goals

Comparisons

Studies

About

Contact

Search...

Search...

Explore the science. Follow the connections.

Start with a peptide, a goal, a mechanism, or a study. Discover how every piece of research connects across the platform.

Search peptides, goals, studies,...

Research made connected. Build for curious minds.

© 2026 All rights reserved

This platform is for informational and research purposes only. It does not provide medical advice. Always consult a qualified healthcare provider.

Explore the science. Follow the connections.

Start with a peptide, a goal, a mechanism, or a study. Discover how every piece of research connects across the platform.

Search peptides, goals, studies,...

Research made connected. Build for curious minds.

© 2026 All rights reserved

This platform is for informational and research purposes only. It does not provide medical advice. Always consult a qualified healthcare provider.

Explore the science. Follow the connections.

Start with a peptide, a goal, a mechanism, or a study. Discover how every piece of research connects across the platform.

Search peptides, goals, studies,...

Research made connected. Build for curious minds.

© 2026 All rights reserved

This platform is for informational and research purposes only. It does not provide medical advice. Always consult a qualified healthcare provider.